Survival Difference between Surgery Versus Non-Surgery for the Treatment of Hepatocellular Carcinoma Patients at Liver Centre, Malaysia

Azmawati Mohammed Nawi, Azmi Mohd Tamil, Krishnan Raman

Abstract


Hepatic resection, the only treatment that offers long term survival for patients with Hepatocellular carcinoma (HCC), have shown significant improvement in results over the past decades. The aim of the study was to compare the survival between patients receiving and not receiving surgery. A retrospective cohort study measured the survival of newly diagnosed cases of HCC patients who underwent treatment in Selayang Hospital from 1 January 2003 till 31 December 2006. Survival time was measured from the date of diagnosis until the subjects died or until the end of study period (31 December 2007). Overall survival was significantly longer in surgery group in comparison with non-surgery group with a median survival of 43 and 20 months, respectively (p<0.001). The following factors were noted to have improved survival duration with surgical resection; Child Pugh Class B patients, tumor size less or more than 4cm and number of nodules less than 3. Subgroup analysis showed improved survival duration with surgical resection among patients with Child Pugh Class B with tumor size less than 4cm or with nodule less than 3 and patients who had less than 3 nodules, even with tumor size of less or more than 4cm. Multivariate Cox Re-gression showed surgical intervention significantly improved survival time for overall patients (Adjusted HR: 1.5) while non-surgery improved survival in patients with tumor size less than 4cm (Adjusted HR: 0.4). Surgical resection significantly improved the survival duration in overall patients while non-surgical procedure improved survival if the tumor size was less than 4cm.

Keywords


10 Survival Difference between Surgery Versus Non-Surgery for the Treatment of Hepatocellular Carcinoma Patients at Liver Centre, Malaysia Azmawati MN1(), Azmi MT 1, Krishnan R2 1Department of Community Health, Universiti Kebangsaan Malaysia Medical Cent

Full Text:

PDF

References


Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden. Inter J Cancer 2001; 94(2): 153– 156.

National Cancer Registry. The first report of the National Cancer registry cancer incidence in Malaysia. Kuala Lumpur: Ministry of Health 2002.http://www.radiologymalaysia.org/index/Directories_index.html. Last accessed on 24.05.2011

The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma Japan. Cancer 1994; 74(10):2272– 80.

Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma toward zero hospital deaths. Ann Surg 1999; 229(3):322– 30.

Torzilli G, Makuuchi M, Inoue K, et al. No mortality liver resection for hepatocellular carcinoma in cirrhotic and non cirrhotic patients: Is there a way? A prospective analysis of our approach. Arch Surg 1999; 134(9):984 –92.

Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 1999; 229(6):790 – 800.

Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000; 191(4):381– 8.

Fuster J, Garcia-Valdecasas JC, Grande L, et al. Hepatocellular carcinoma and cirrhosis: results of surgical treatment in a European series. Ann Surg 1996; 223(3):297–302.

Lau H, Fan ST, Ng IOL, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998; 83(11):2302.

Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994; 219(3):236 – 47.

Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74(3):817–25.

Allgaier HP, Deibert P, Zuber I, et al. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999; 353(9165):1676 –7.

Arii S, Yamaoka Y, Futagawa S. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32(6):1224 –9.

Poon RT, Fan ST, Lo CM. Improving survival results after resection of hepatocellular carcinoma:

a prospective study of 377 patients over 10 years. Ann Surg 2001; 234(1):63–70.

Verhoef C, Visser O, de Man RA, Wilt J. Ijzermans JNM & Janssen-Heijnen MNG. Hepatocelullar Cancer in the Netherlands incidence, treatment and survival patterns. European journal of cancer 2004; 40(10): 1530-1538.

Bruix J, Sherman M, Llovet JM. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35(3):421–430.

Hashikura Y, Kawasaki S, Terada M. Long-term results of living-related donor liver graft transplantation: a single center analysis of 110 patients. Transplantation 2001; 72(1):9599.

Hong SN, Lee SY, Choi MS et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001; 234(1):71–78.

Farinati F, Gianni S , Marin, Fagiuoli S, Rinaldi M, Naccarato R. Does the choice of treatment influence survival of patients with small Hepatocelullar Cancer in compensated cirrhosis? Lippincott Wiliams & Wilkins 2001; 13(10): 1217-1224.

Livraghi T, Bolondi L, Buscarini L et al. No treatment, resection and ethanol injection in Hepatocelullar Cancer: A retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. Journal of Hepatology 1995; 22(5):522-6.

Maluccio M., Covey AM, Gandhi R, Gonen, Mithat. Getrajdman GI et al. Comparison of Survival Rates after TransArterial Embolization and Ablation Versus Surgical Resection for Treating Solitary Hepatocellular Carcinoma up to 7cm. Journal Of vascular and interventional radiology 2005; 16(7): 955-961.

Atsushi N, Junichi M, Satoshi M et al. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated score. World Journal Gastroenterology 2008; 14(1): 58-63.

Jerome HL, Pauline WC, Steven MA, Ronald WB, & Clifford YK Surgery for Hepatocellular Carcinoma: Does It Improve Survival? Annals of Surgical Oncology 2004;11(3):298–303.

Tito L, Luigi B, Luigi B, Mario C et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995; 22(5):522-526.

Alfredo G, Andrea R, Alessandro V et al. Radiofrequency Ablation Versus Surgical Resection for the Treatment of Hepatocellular Carcinoma in Cirrhosis.J Gastrointest Surg 2008; 12(1):192–198.


Refbacks

  • There are currently no refbacks.


e-issn 2231-7481